Moreover, unaffected by changes in the symptoms of Non-alcoholic Fatty Liver Disease (NAFLD) such as obesity, fat mass, insulin resistance, lipids, and blood pressure, VLCKD is an effective treatment for this condition [12]. The gene discussed is INS; the disease is metabolic dysfunction-associated steatotic liver disease.